title: HLA status in patients with chronic spontaneous urticaria.
abstract: Chronic spontaneous urticaria (CSU) is the most common form of chronic urticaria. A considerable amount of data supports an immunological basis for CSU. Some research has focused on the association between chronic urticaria and specific human leukocyte antigen (HLA) alleles. The aim of this study was to investigate the HLA status of Polish patients diagnosed with CSU.
  
  
  METHODS
  The standard complement-dependent microlymphocytotoxicity assay and PCR amplification with sequence-specific primers were used to analyze HLA alleles in 115 patients diagnosed with CSU, and the results were compared to those from 162 healthy, genetically unrelated individuals.
  
  
  RESULTS
  Among the HLA-A alleles, A-33 occurred significantly more often in the control group (p < 0.01). Analysis of the HLA-B allele frequencies revealed the prevalence of the B44 antigen in the study group (p < 0.0001). Frequencies of HLA-C alleles and HLA-DQ did not differ significantly between the groups. Among the HLA class II alleles, DRB1*04 was observed significantly more often in the study population (p < 0.001), mainly in the autoimmunological subtype of urticaria.
  
  
  CONCLUSIONS
  HLA alleles may be involved in CSU development or play a protective role in CSU.
authors.affiliation: Clinical Department of Internal Medicine, Dermatology and Allergology, Medical University of Silesia, Zabrze, Poland. andrzejbozek@o2.pl
authors.forename: Andrzej
authors.initials: A
authors.lastname: Bozek
authors.forename: Jolanta
authors.initials: J
authors.lastname: Krajewska
authors.forename: Barbara
authors.initials: B
authors.lastname: Filipowska
authors.forename: Jolanta
authors.initials: J
authors.lastname: Polanska
authors.forename: Regina
authors.initials: R
authors.lastname: Rachowska
authors.forename: Alicja
authors.initials: A
authors.lastname: Grzanka
authors.forename: Jerzy
authors.initials: J
authors.lastname: Jarzab
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D005787:Gene Frequency; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D015234:HLA-A Antigens / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D015235:HLA-B Antigens / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D059948:HLA-B44 Antigen; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D059811:HLA-DRB1 Chains; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D011044:Poland; D011110:Polymorphism, Genetic; D014581:Urticaria / Q000235:genetics* / Q000276:immunology*
chemical_list: D015234:HLA-A Antigens; C082945:HLA-A*33 antigen; D015235:HLA-B Antigens; D059948:HLA-B44 Antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; C527195:HLA-DRB1*04 antigen